Evidence map›Paper›PMID 28203057›Full record

ArticleDrug design, development and therapy2017

Hamed Karimian, Aditya Arya, Mehran Fadaeinasab, Mahboubeh Razavi, Maryam Hajrezaei, Ataul Karim Khan, Hapipah Mohd Ali, Mahmood Ameen Abdulla, Mohamad Ibrahim Noordin

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Drug design, development and therapy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Pharmacological Activities of Turmerones.Current medicinal chemistry · 2025
    Review
  2. Article
  3. Phenolic compounds fromSaudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2018
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Hamed KarimianDepartment of Pharmacy, Faculty of Medicine, University of Malaya, Kuala Lumpur.
Aditya AryaSchool of Medicine, Taylor's University, Subang Jaya.
Mehran FadaeinasabCentre for Natural Products Research and Drug Discovery.
Mahboubeh RazaviDepartment of Pharmacy, Faculty of Medicine, University of Malaya, Kuala Lumpur.
Maryam HajrezaeiDepartment of Biomedical Science, Faculty of Medicine, University of Malaya, Kuala Lumpur.
Ataul Karim KhanDepartment of Pharmacy, Faculty of Medicine, University of Malaya, Kuala Lumpur.
Hapipah Mohd AliCentre for Natural Products Research and Drug Discovery.
Mahmood Ameen AbdullaDepartment of Biomedical Science, Faculty of Medicine, University of Malaya, Kuala Lumpur.
Mohamad Ibrahim NoordinDepartment of Pharmacy, Faculty of Medicine, University of Malaya, Kuala Lumpur; Malaysian Institute of Pharmaceuticals and Nutraceuticals (IPharm), Pulau Pinang, Malaysia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe aim of this study was to evaluate the anticancer potential of MATERIALS AND

methods

resultsOur results demonstrated that

conclusionThis study demonstrated that

Indexed as

AnimalsAntineoplastic Agents, PhytogenicApiaceaeApoptosisCell Line, TumorCell ProliferationCell SurvivalCyclin-Dependent Kinase Inhibitor p21Cyclin-Dependent Kinase Inhibitor p27Dose-Response Relationship, DrugDrug Screening Assays, AntitumorFemaleHumansMammary Neoplasms, ExperimentalMolecular ConformationPlant ExtractsAntineoplastic Agents, PhytogenicCyclin-Dependent Kinase Inhibitor p21Cyclin-Dependent Kinase Inhibitor p27Plant Extractsapoptosisbreast cancerchemopreventionintrinsic pathwayKelussia odoratissimaMCF7

Identifiers

PMID28203057
PMCPMC5293364

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.